{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10962577", "DateCompleted": {"Year": "2000", "Month": "10", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0950-9232", "JournalIssue": {"Volume": "19", "Issue": "36", "PubDate": {"Year": "2000", "Month": "Aug", "Day": "24"}}, "Title": "Oncogene", "ISOAbbreviation": "Oncogene"}, "ArticleTitle": "Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.", "Pagination": {"StartPage": "4159", "EndPage": "4169", "MedlinePgn": "4159-69"}, "Abstract": {"AbstractText": ["The transcription factor nuclear factor-kappaB (NF-kappaB) regulates genes important for tumor invasion, metastasis and chemoresistance. Normally, NF-kappaB remains sequestered in an inactive state by cytoplasmic inhibitor-of-kappaB (IkappaB) proteins. NF-kappaB translocates to nucleus and activates gene expression upon exposure of cells to growth factors and cytokines. We and others have shown previously that NF-kappaB is constitutively active in a subset of breast cancers. In this study, we show that constitutive activation of NF-kappaB leads to overexpression of the anti-apoptotic genes c-inhibitor of apoptosis 2 (c-IAP2) and manganese superoxide dismutase (Mn-SOD) in breast cancer cells. Furthermore, expression of the anti-apoptotic tumor necrosis factor receptor associated factor 1 (TRAF1) and defender-against cell death (DAD-1) is regulated by NF-kappaB in certain breast cancer cells. We also demonstrate that NF-kappaB-inducible genes protect cancer cells against paclitaxel as MDA-MB-231 breast cancer cells modified to overexpress IkappaBalpha required lower concentrations of paclitaxel to arrest at the G2/M phase of the cell cycle and undergo apoptosis when compared to parental cells. The effect of NF-kappaB on paclitaxel-sensitivity appears to be specific to cancer cells because normal fibroblasts derived from embryos lacking p65 subunit of NF-kappaB and wild type littermate embryos were insensitive to paclitaxel-induced G2/M cell cycle arrest. Parthenolide, an active ingredient of herbal remedies such as feverfew (tanacetum parthenium), mimicked the effects of IkappaBalpha by inhibiting NF-kappaB DNA binding activity and Mn-SOD expression, and increasing paclitaxel-induced apoptosis of breast cancer cells. These results suggest that active ingredients of herbs with anti-inflammatory properties may be useful in increasing the sensitivity of cancers with constitutively active NF-kappaB to chemotherapeutic drugs. Oncogene (2000) 19, 4159 - 4169"]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, IN 46202, USA."}], "Identifier": [], "LastName": "Patel", "ForeName": "N M", "Initials": "NM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nozaki", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shortle", "ForeName": "N H", "Initials": "NH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bhat-Nakshatri", "ForeName": "P", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Newton", "ForeName": "T R", "Initials": "TR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rice", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gelfanov", "ForeName": "V", "Initials": "V"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Boswell", "ForeName": "S H", "Initials": "SH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Goulet", "ForeName": "R J", "Initials": "RJ", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sledge", "ForeName": "G W", "Initials": "GW", "Suffix": "Jr"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Nakshatri", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Oncogene", "NlmUniqueID": "8711562", "ISSNLinking": "0950-9232"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Apoptosis Regulatory Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Caenorhabditis elegans Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Dad-1 protein, C elegans"}, {"RegistryNumber": "0", "NameOfSubstance": "I-kappa B Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Inhibitor of Apoptosis Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "NFKBIA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Repressor Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "TNF Receptor-Associated Factor 1"}, {"RegistryNumber": "139874-52-5", "NameOfSubstance": "NF-KappaB Inhibitor alpha"}, {"RegistryNumber": "2RDB26I5ZB", "NameOfSubstance": "parthenolide"}, {"RegistryNumber": "9007-49-2", "NameOfSubstance": "DNA"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "P88XT4IS4D", "NameOfSubstance": "Paclitaxel"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Apoptosis Regulatory Proteins"}, {"QualifierName": [], "DescriptorName": "Blotting, Northern"}, {"QualifierName": [], "DescriptorName": "Blotting, Western"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Caenorhabditis elegans Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA"}, {"QualifierName": ["metabolism"], "DescriptorName": "DNA-Binding Proteins"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "I-kappa B Proteins"}, {"QualifierName": [], "DescriptorName": "Inhibitor of Apoptosis Proteins"}, {"QualifierName": [], "DescriptorName": "NF-KappaB Inhibitor alpha"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Paclitaxel"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Repressor Proteins"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}, {"QualifierName": [], "DescriptorName": "TNF Receptor-Associated Factor 1"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "8", "Day": "30", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "10", "Day": "7", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "8", "Day": "30", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10962577", "10.1038/sj.onc.1203768"]}}], "PubmedBookArticle": []}